Clinical trial NCT07007299: Safety and Efficacy of Integrative Korean Medicine Treatment for Elderly After Traffic Accident
Official title: Safety and Efficacy of Integrative Korean Medicine Treatment for Elderly After Traffic Accident: Retrospective Chart Review Study
Study type: OBSERVATIONAL
Overall status: RECRUITING
Conditions: Musculoskeletal Diseases or Conditions
Traffic Accident
Elderly (People Aged 65 or More)
Keywords: pharmacopuncture
herbal medicine
elderly
korean medicine
complementary and alternative medicine
acupuncture
Lead sponsor: Jaseng Medical Foundation
Sponsor class: OTHER
First posted: 2025-06-05
Enrollment: 1500
Sex: ALL
Minimum age (years): 65
Standard ages: OLDER_ADULT
Accepts healthy volunteers: no
Observational model: OTHER
Time perspective: RETROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: From January 1, 2021 to December 31, 2023, only patients aged 65 years or older who visited the four branches of Jaseng Oriental Hospital (Gangnam, Bucheon, Daejeon, Haeundae) and received inpatient treatment after being injured in a traffic accident and who meet the selection criteria are eligible.

Brief summary: The purpose of this study was to analyze the medical records of elderly traffic accident patients hospitalized at 4 branches of Jaseng Korean Medicine Hospital to determine the status of elderly patients and the effectiveness and safety of Korean medicine combination treatment.

Detailed description: This study was retrospective chart review study and was conducted in 4 branches of Jaseng Korean Medicine Hospital (Gangnam, Bucheon, Daejeon, Haeundae).

Eligibility criteria: Inclusion Criteria:

* Patients aged 65 years or older at the time of first visit
* Patients who visited our hospital due to symptoms caused by a traffic accident and received integrated oriental medicine treatment at least once as an inpatient treatment

Exclusion Criteria:

* If only consultation was conducted at the hospital or only Western medicine treatment was conducted
* If only outpatient treatment was received without hospitalization
* If other researcher judges that participation in the study is difficult

Primary outcomes:
measure: Numeric Rating Scale (NRS)
timeFrame: The results are measured for each patient at admission (before) and discharge (after) from January 2021 to December 31, 2023.
Secondary outcomes:
measure: euroqol-5 dimension (EQ-5D)
timeFrame: The results are measured for each patient at admission (before) and discharge (after) from January 2021 to December 31, 2023.
measure: Neck Disability Index (NDI)
timeFrame: The results are measured for each patient at admission (before) and discharge (after) from January 2021 to December 31, 2023.
measure: Oswestry Disability Index (ODI)
timeFrame: The results are measured for each patient at admission (before) and discharge (after) from January 2021 to December 31, 2023.
measure: Adverse Events (AE)
timeFrame: The period of hospitalization is limited to January 2021 to December 2023.
Other outcomes:
Locations:
city: Seoul
country: Korea, Republic of
facility: Jaseng Hospital of Korean Medicine
state: Gangnam-Gu
city: Bucheon
country: Korea, Republic of
facility: Bucheon Jaseng Hospital of Korean Medicine
state: Gyeonggi
city: Busan
country: Korea, Republic of
facility: Haeundae Jaseng Hospital of Korean Medicine
city: Daejeon
country: Korea, Republic of
facility: Daejeon Jaseng Hospital of Korean Medicine
Study officials:
affiliation: Jaseng Medical Foundation
name: In-Hyuk Ha, Ph.D
role: STUDY_DIRECTOR
References: